Oxaloacetate May Ease Chemo Brain After Breast Cancer
A UCLA Health Jonsson Comprehensive Cancer Center-led study found that an oxaloacetate supplement may improve cognitive function and reduce fatigue in some breast cancer survivors after treatment.
This article was automatically drafted and passed editorial compliance checks. It synthesizes public source metadata and is not a substitute for individual care or clinical review.
Researchers led by the UCLA Health Jonsson Comprehensive Cancer Center studied a nutritional supplement containing oxaloacetate, a molecule naturally present in the body that helps cells produce energy. Their findings suggest that the supplement may help ease post-treatment brain fog and fatigue for some breast cancer survivors.
What the study found
The UCLA-led team linked the oxaloacetate supplement with possible improvements in cognitive function and fatigue after breast cancer treatment. The finding concerns symptoms commonly described as chemo brain or brain fog rather than treatment of the cancer itself.
How to interpret the finding
The researchers framed the benefit as a possibility for some breast cancer survivors. That wording reflects uncertainty and does not establish that every survivor will experience cognitive or fatigue improvement from oxaloacetate.
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.
